Dissolution enhancement of artemisinin with β-cyclodextrin

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 5, 2011, Pages 646-652

  Kakran, Mitali ^a   Sahoo, Nanda Gopal ^a   Li, Lin ^a   Judeh, Zaher ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b Nanyang Technological University   (Singapore)

Author keywords

cyclodextrin; Artemisinin; Dissolution; Orthorhombic; Triclinic

Indexed keywords

ARTEMISININ; BETA CYCLODEXTRIN;

ARTICLE; CRYSTAL STRUCTURE; DRUG SOLUBILITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANTI-INFECTIVE AGENTS; ARTEMISININS; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; SCATTERING, SMALL ANGLE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUSPENSIONS; X-RAY DIFFRACTION;

EID: 79955603029     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.646     Document Type: Article

References (28)

1. Balint G. A., Pharmacol. Ther., 90, 261-265 (2001).
2. Dhingra V., Rao K. V., Narasu M. L., Life Sci., 66, 279-300 (2000).
3. Oh S., Kim B. J., Singh N. P., Lai H., Sasaki T., Cancer Lett., 274, 33-39 (2009).
4. Marconi G., Monti S., Manoli F., Esposti A. D., Guerrini A., Helv. Chim. Acta, 87, 2368-2377 (2004).
5. Subramaniam B., Rajewski R. A., Snavely K., J. Pharm. Sci., 86, 885-890 (1997).
6. Hancock B. C., Zografi G., J. Pharm. Sci., 86, 1-12 (1997).
7. Grau M. J., Kayser O., Muller R. H., Int. J. Pharm., 196, 155-157 (2000).
8. Wong J. W., Yuen K. H., Int. J. Pharm., 227, 177-185 (2001).
9. Sharma U. S., Balasubramanian S. V., Straubinger R. M., J. Pharm. Sci., 84, 1223-1230 (1995).
10. Wong J. W., Yuen K. H., Drug Dev. Ind. Pharm., 29, 1035-1044 (2003).
11. Kakran M., Sahoo N. G., Li L., Judeh Z., J. Pharm. Pharmacol., 62, 413-421 (2010).
12. Kakran M., Sahoo N. G., Li L., Judeh Z., Panda P., J. Biomater. Sci. Polym. Ed., 22, 363-378 (2011).
13. Chan K. L., Yuen K. H., Takayanagi H., Janadasa S., Peh K. K., Phytochemistry, 46, 1209-1214 (1997).
14. Kakran M., Sahoo N. G., Li L., Judeh Z., Wang Y., Chong K., Loh L., Int. J. Pharm., 383, 285-292 (2010).
15. Zhao S. S., Analyst, 112, 661-664 (1987).
16. Sahoo N. G., Abbas A., Judeh Z., Li C. M., Yuen K. H., J. Pharm. Sci., 98, 281-296 (2009).
17. Higuchi T., Connors K. A., Adv. Anal. Chem. Instr., 4, 117-212 (1965).
18. Martin A., "Physical Pharmacy, Physical Chemical Principles in the Pharmaceutical Sciences," 4th ed., Lea and Febiger, Philadelphia, 1993.
19. Ahuja N., Katare O. P., Singh B., Eur. J. Pharm. Biopharm., 65, 26-38 (2007).
20. Khan K. A., J. Pharm. Pharmacol., 27, 48-49 (1975).
21. Costa F. O., Sousa J. J. S., Pais A. A. C. C., Formosinho S. J., J. Controlled Release, 89, 199-212 (2003).
22. Costa P., Lobo J. M. S., Eur. J. Pharm. Sci., 13, 123-133 (2001).
23. Hussein K., Türk M., Wahl M. A., Pharm. Res., 24, 585-592 (2007).
24. Jensen C. E., dos Santos R. A., Denadai A. M., Santos C. F., Braga A. N., Sinisterra R. D., Molecules, 15, 4067-4084 (2010).
25. Reppas C., Nicolaides E., "Oral Drug Absorption Prediction and Assessment," ed. by Dressman J. B., Lennernas H., Marcel Dekker, New York, 2000, pp. 229-254.
26. Noyes A. A., Whitney W. R., J. Am. Chem. Soc., 19, 930-934 (1897).
27. Lisgarten J. N., Potter B. S., Bantuzeko C., Palmer R. A., J. Chem. Crystallogr., 28, 539-543 (1998).
28. Marconi G., Monti S., Manoli F., Esposti A. D., Mayer B., Chem. Phys. Lett., 383, 566-571 (2004).